what is the difference between tirzepatide and wegovy Despite substantial weight loss, most obesity drugs such as Mounjaro do not meaningfully improve quality of life and few show cardiovascular benefits at one year, finds a new study in Wegovy vs Mounjaro | Semaglutide

Patients taking blood thinners require careful monitoring, though serious complications remain rare in clinical practice

Nausea may worsen

Therefore, an understanding of the long-term economic value of these medications is necessary for patients, providers, and policymakers, and additional studies are needed to assess their lifetime cost-effectiveness

[14] [15] Other potential concerns include: Hypoglycaemia risk in patients with diabetes, particularly if taking other glucose-lowering medications Kidney stone formation associated with topiramate, potentially exacerbated by dehydration from gastrointestinal side effects Acute kidney injury risk from severe dehydration due to gastrointestinal adverse effects Metabolic acidosis from topiramate, which requires monitoring of serum bicarbonate levels Pancreatitis and gallbladder disease associated with GLP-1 receptor agonists like tirzepatide Pregnancy risks : topiramate is teratogenic and subject to a Pregnancy Prevention Programme